Boothbay Fund Management, LLC Ascendis Pharma A/S Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $615,762 - $735,603	-5,063 Reduced 64.84%	2,745 $361,000
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $392,748 - $544,949	-3,144 Reduced 28.71%	7,808 $1.01 Million
Q4 2020 Feb 12, 2021	BUY	$151.2 - $182.76 $1.66 Million - $2 Million	10,952 New	10,952 $1.83 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $2.48 Million - $3.06 Million	-23,167 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $1.44 Million - $3.01 Million	23,167 New	23,167 $2.73 Million

236

60.2M

80.3K

216K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.55B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.